Pharmacokinetics of atracurium and other non-depolarizing neuromuscular blocking agents in normal patients and those with renal or hepatic dysfunction.
Miller
R D
RD
D000818:Animals; D001279:Atracurium; D002648:Child; D002675:Child, Preschool; D004285:Dogs; D006801:Humans; D007546:Isoquinolines / Q000378:metabolism*; D007674:Kidney Diseases / Q000378:metabolism*; D007700:Kinetics; D008107:Liver Diseases / Q000378:metabolism*; D009466:Neuromuscular Blocking Agents / Q000378:metabolism*; D010197:Pancuronium / Q000031:analogs & derivatives / Q000378:metabolism; D014673:Vecuronium Bromide
D007546:Isoquinolines; D009466:Neuromuscular Blocking Agents; D001279:Atracurium; D014673:Vecuronium Bromide; D010197:Pancuronium